Abstract
Stroke and Alzheimer’s disease (AD) are leading causes of dementia in developed countries. Up until now, both diseases, vascular dementia (VaD) and AD were considered as completely different entities with their own physiopathology. The former due to a brain circulation impairment, and the latter due to a primary brain degenerative disorder. However recent epidemiological studies as well as neuropathological findings have suggested common features between both entities. Thus some authors have suggested the ‘vascular hypothesis of AD’, considering AD as a vascular disease with neurodegenerative consequences or ‘vasocognopathy’. This has pharmacological implications as it opens up the possibility for novel therapeutic approaches for treatment of AD, for example by stimulation of angiogenesis in the brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott NJ, Ronnback L, et al. (2006) Astrocyte-endothelial interactions at the blood brain barrier. Nat Rev Neurosci 7:41–53.
Aliev G, Seyidova D, et al. (2002) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 977:45–64.
Almeida A, Paul Thiery J, et al. (2004) Gene expression analysis by real-time reverse transcription polymerase chain reaction: Influence of tissue handling. Anal Biochem 328:101–108.
Al Qteishat A, Gaffney JJ, et al. (2006) Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport 17:1111–1114.
Altman J (1963) Autoradiographic investigation of cell proliferation in the brains of rats and cats. Anatomical records 145:573–591.
Arenillas JF, Sobrino T, et al. (2007) The role of angiogenesis in damage and recovery from ischemic stroke. Curr Treat Options Cardiovasc Med 9:205–212.
Appelros P, Samuelsson M, et al. (2005) Lacunar infarcts: Functional and cognitive outcomes at five years in relation to MRI findings. Cerebrovasc Dis 20:34–40.
Arboix A, Roig H, et al. (2004) Differences between hypertensive and non-hypertensive ischemic stroke. Eur J Neurol 11:687–692.
Arboix A, Miguel M, et al. (2006) Cardiovascular risk factors in patients aged 86 or older with ischemic stroke. Clin Neurol Neurosurg 108:638–643.
Arboix A, Martí-Vilalta JL (2009) Lacunar stroke. Expert Rev Neurother 9:179–196.
Arvidsson A, Kokaia Z, et al. (2001) N-methyl-d-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci 14:10–18.
Asai T, Ohkubo T, et al. (2001) Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: The Ohasama Study. Hypertension 38:1321–1324.
Babikian V, Ropper AH (1987) Binswanger’s disease: A review. Stroke 18:2–12.
Ballard C, Mc Keith I, et al. (2000) Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 11:59–65.
Barden AE, Herbison CE, et al. (2001) Association between the endothelin-1 gene Lys198Asn polymorphism, blood pressure, and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 19:1775–1782.
Benavente O, White CL, et al. (2005) Small vessel strokes. Current Cardiology Reports 7:23–28.
Benoit SC, Clegg DJ, et al. (2004) Insulin and leptin as adiposity signals. Recent Prog Horm Res 59:267–285.
Berr C, Akbaraly TN, et al. (2007) Epidemiology of dementia. Presse Med 36:1431–1441.
Besson G, Hommel M, et al. (2000) Risk factors for lacunar infarcts. Cerebrovasc Dis 10:387–390.
Biessels GJ, Stackcenborg S, et al. (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5:64–74.
Blacker D, Haines JL, et al. (1997) ApoE-4 gene at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology 48:139–147.
Bodowitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436–4440.
Bozzali M, Falini A, et al. (2002) White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72:742–746.
Breteler MM (2000) Vascular involvement in cognitive decline and dementia: Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan study. Ann NY Acad Sci 903:457–465.
Brust JCM (1983) Vascular dementia- still over diagnosed. Stroke 14:298–300.
Castensson A, Emilsson L, et al. (2000) High-resolution quantification of specific mrna levels in human brain autopsies and biopsies. Genome Res 10:1219–1229.
Cechetto DF, Hachinski V, et al. (2008) Vascular risk factors and Alzheimer’s disease. Expert Rev Neurother 8:743–750.
Chao MV (2000) Trophic factors: An evolutionary cul-de-sac or door into higher neuronal function? J Neurosci Res 59:353–355.
Chen J, Zacharek A, et al. (2009) Treatment of stroke with a synthetic liver x receptor agonist, to901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab
Chui H (2001) Dementia due to subcortical ischaemic vascular disease. Clin Cornestone 3:40–51.
Chukwudelunzu FE, Meschia JF, et al. (2001) Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry 71:658–662.
Clavier I, Hommel M, et al. (1994) Long-term prognosis of symptomatic lacunar infarct: A hospital based study. Stroke 25:2005–2009.
Coffey CE, Figiel GS, et al. (1989)White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatr Clin Neurosci 1:135–144 .
Corbett A, Bennett H, et al. (1994) Cognitive dysfunction following subcortical infarction. Arch Neurol 51:999–1007.
Cummings JL (1993) Frontal-subcortical circuits and human behaviour. Arch Neurol 50:873–880.
Damasio AR, Damasio H, et al. (1982) Aphasia with nonhemorrhagic lesions in the basal ganglia and internal capsule. Arch Neurol 19:15–24.
DeCarli C, Miller B, et al. (1999) Predictors of brain morphology for the men of the NHLBI twin study. Stroke 30:529–536.
De Haan EH, Nys GM, et al. (2006) Cognitive function following stroke and vascular cognitive impairment. Curr Opin Neurol 19:559–564.
De la Torre JC, Stefano GB (2000) Evidence that Alzheimer’s disease is a microvascular disorder: Role of constitutive nitric oxide. Brain Res Rev 34:119–136.
De la Torre JC (2002a) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33:1152–1162.
De la Torre JC (2002b) Vascular basis of Alzheimer’s pathogenesis. Ann NY Acad Sci 977: 196–215.
De la Torre JC (2004a) Alzheimer’s disease is a vasocognopathy: A new term to describe its nature. Neurol Res 26:517–524.
De la Torre JC (2004b) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol 3:184–190.
De la Torre JC (2005) Cerebrovascular gene linked to Alzheimer’s disease pathology. Trends in Mol Med 11:534–536.
De la Torre JC (2006) How do heart disease and stroke become risk factors for Alzheimer’s disease? Neurol Res 28:637–644.
De la Torre JC (2008) Pathophisiology of neuronal energy crisis in Alzheimer’s disease. Neurodegenerative Dis 5:126–132.
Di Carlo A, Launer LJ, et al. (2000) Frequency of stroke in Europe: A collaborative study of population-based cohorts- ILSA Working Group and the Neurologic Diseases in the Elderly Research Group: Italian Longitudinal Study on Aging. Neurology 54 (11 suppl 5):S28–33.
Draganski B, Gaser C, et al. (2004) Neuroplasticity: Changes in grey matter induced by training. Nature 427:311–312.
Eichner JE, Dunn ST, et al. (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487–495.
Englund E, Sjöbeck M, (2004) Diffusion tensor MRI post mortem demonstrated cerebral white matter pathology. J Neurol 251:350–352.
Eriksson PS, Perfilieva E, et al. (1998) Neurogenesis in the adult human hippocampus. Nat Med 4:1313–1317.
Erkinjuntti T, Bowler JV, et al. (1999) Imaging of static brain lesions in vascular dementia: Implications for clinical trial. Alzheimer Dis Assoc Disord 13 (suppl):81–90.
Erkinjuntti T, Inzitari D, et al. (2000) Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann NY Acad Sci 903:262–272.
Erkinjuntti T, Pantoni L (2000) Subcortical vascular dementia. In: Gauthier S, Cummings JL (Eds). Yearbook of Alzheimer’s Disease and related Disorders. Martin Dunitz, London, UK 101–133.
Erkinjuntti T, Roman G, et al. (2004) Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 35:1010–1017.
Erkinjuntti T (2007) Vascular cognitive deterioration and stroke. Cerebrovasc Dis 24 (Suppl 1):189–194.
Erkinjuntti T, Gauthier S (2009) The concept of vascular cognitive impairment. Front Neurol Neurosci 24:79–85.
Esiri MM, Wicock GK, et al. (1997) Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63:749–753.
Esiri MM, Nagy Z, et al. (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 354:919–920.
Fein G, Di Sclafani V, et al. (2000) Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55:1626–1635.
Ferro JM, Kertesz A (1984) Posterior internal capsule infarction associated with neglect. Arch Neurol 41:422–424.
Fisher CM (1965) Pure sensory stroke involving face, arm and leg. Neurology 15:76–80.
Fisher C (1982) Lacunar strokes and infarcts: A review. Neurology 32:871–876.
Ford G, Xu Z, et al. (2006) Expression analysis systematic explorer (ease) analysis reveals differential gene expression in permanent and transient focal stroke rat models. Brain Res 1071:226–236.
Frisoni GB, Galluzzi S, et al. (2002) Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 249:1423–1432.
Gamaldo A, Moghekar A, et al. (2006) Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 67:1363–1369.
Gold G, Kövari E, et al. (2005) Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 36:1184–1188.
Gormley K, Bevan S, et al. (2007) Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovasc Dis 23:148–155.
Grau-Olivares M, Bartrés-Faz D, et al. (2007a) Mild cognitive impairment after lacunar infarction: Voxel-bassed morphometry and neuropsychological assessment. Cerebrovasc Dis. 23:353–361.
Grau-Olivares, Arboix A, et al. (2007b) Neuropsychological abnormalities associated with lacunar infarction. J Neurol Sci 257:160–165.
Grau-Olivares M, Arboix A (2009) Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: A forerunner of vascular dementia? Expert Rev Neurother 9:1201–1217.
Gretarsdottir S, Thorleifsson G, et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35:131–138.
Guermazi A, Miaux Y, et al. (2007) Neuroradiological findings in vascular dementia. Neuroradiology 49:1–22.
Gustafson D (2006) Adiposity indices and dementia. Lancet Neurol 5:713–720.
Hachinski VC, Lassen NA, et al. (1974) Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet 2:207–210.
Henon H, Pasquier F, et al. (2006) Poststroke dementia. Cerebrovasc Dis 22:61–70.
Henry-Feugeas MC (2008) Alzheimer’s disease in late-life dementia: A minor toxic consequence of devastating cerebrovascular dysfunction. Medical Hypotheses 70:866–875.
Huang EJ, Reichardt LF (2001) Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24:677–636.
Hynd MR, Lewohl JM, et al. (2003) Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 85:543–562.
Ikonomidou C, Stefovska V, et al. (2000) Neuronal death enhanced by n-methyl-d-aspartate antagonists. Proc Natl Acad Sci USA 97:12885–12890.
Issa R, AlQteishat A, et al. (2005) Expression of basic fibroblast growth factor mrna and protein in the human brain following ischaemic stroke. Angiogenesis 8:53–62.
Jackson C, Sudlow C (2005) Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 36:891–901.
Johansson BB (2000) Regeneration and plasticity in the brain and spinal cord. J Cereb Blood Flow Metab 27:1417–1430.
Johnson KA, Albert MS (2000) Perfusion abnormalities in prodromal Alzheimer’s disease. Neurobiol Aging 21:289–292.
Kim JB, Piao CS, et al. (2004) Delayed genomic responses to transient middle cerebral artery occlusion in the rat. J Neurochem 89:1271–1282.
Kim JS, Choi D, et al. (2004) Complete revascularization of total obstruction of both subclavian arteries and descending abdominal aorta by combined surgery and percutaneous transluminal angioplasty. J Invasive Cardiol 16:508–510.
Kim OS, Park EJ, et al. (2002) Jak-stat signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem 277:40594–40601.
Kivipelto M, Helkala EL, et al. (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137:149–155.
Kokaia Z, Lindvall O (2003) Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol 13:127–132.
Kogure D, Matsuda H, et al. (2000) Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. J Nucl Med 41:1155–1162.
Krupinski J, Issa R, et al. (1997) A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 28:564–573.
Krupinski J, Kaluza J, et al. (1994) Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25:1794–1798.
Krupinski J, Kumar P, et al. (1996) Increased expression of tgf-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27:852–857.
Kumari M, Brunner E, et al. (2000) Minireview: Mechanisms by which the metabolic syndrome and diabetes impair memory. J Gerontol A Biol Sci Med Sci 5:228–232.
Kwon HM, Kim BJ, et al. (2006) Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37:466–470.
Langa KM, Foster NL, et al. (2004) Mixed dementia: emerging concepts and therapeutic implications. JAMA 292:2901–2908.
Lee RG, van Donkelaar P (1995) Mechanisms underlying functional recovery following stroke. Can J Neurol Sci 22:257–263.
Lembo G, De Luca N, et al. (2001) A common variant of endotelial nitric oxide synthase [Glu298Asp] is an independent risk factor for carotid atherosclerosis. Stroke 32:735–740.
Lippoldt A, Reichel A, et al. (2005) Progress in the identification of stroke-related genes: Emerging new possibilities to develop concepts in stroke therapy. CNS Drugs 19:821–832.
Lizasoain I, Moro A, et al. (2006) Plasticidad, neurogénesis y angiogenesis. In: Montaner J (Ed). En: Fisiopatología de la isquemia cerebral. Marge Medica Books, Barcelona, 179–189.
Lo EH (2008) A new penumbra: Transitioning from injury into repair after stroke. Nat Med 14:497–500.
Lo EH, Dalkara T, et al. (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399–415.
Longa EZ, Weinstein PR, et al. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91.
Longstreth WT, Jr., ManolioTA, et al. (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27:1274–1282.
Lu XC, Williams AJ, et al. (2004) Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 77:843–857.
Luchsinger JA, Reitz C, et al. (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545–551.
Madureira S, Guerreiro M, et al. (1999) A follow-up study of cognitive impairment due to inferior capsular genu infarction. J Neurol 246:764–769.
Marrugat J, Arboix A, et al. (2007) The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev Esp Cardiol 60:573–580.
Martí-Vilalta JL (2004) Enfermedades vasculares cerebrales (2 edición). Prous Science SA, Barcelona. 599 Pp.
Mega MS, Cummings JL (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatr Clin Neurosci 6:358–370.
Meyer JS, Rauch GM, et al. (1999) Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 14:1050–1061.
Meyer EP, Ulmann-Schuler A, et al. (2008) Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer’s disease. Proc Natl Acad Sci USA 105:3587–3592.
Mitsios N, Gaffney J, et al. (2006) Pathophysiology of acute ischaemic stroke: An analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73:159–175.
Moore DF, Li H, et al. (2005) Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: A pilot investigation. Circulation 111:212–221.
Nakamizo T, Nagayama M (2008) Stroke and the genetics of hyperhomocysteinemia. Brain Nerve 60:1295–1306.
Nys GM, van Zandvoort MJ, et al. (2007) Cognitive disorders in acute stroke: Prevalence and clinical determinants. Cerebrovasc Dis 23:408–416.
O’Brien JT, Erkinjuntti T, et al. (2003) Vascular Cognitive Impairment. Lancet Neurol 2:89–98.
Okamura N, Shinkawa M, et al. (2000) Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi 37:974–978.
Orive G, Anitua E, et al. (2009) Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 10:682–692.
Ott A, Stolk RP, et al. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937–1942.
Paglieri C, Bisbocci D, et al. (2008) Hypertension and cognitive function. Clin Exp Hypertens 30:701–710.
Pantoni L, García JH, et al. (1996) Vascular payhology in three cases of progressive cognitive deterioration. J Neurol Sci 135:131–139.
Panza F, D’Introno, et al. (2004) Vascular risk and genetics of sporadic late-onset Alzheimer’s disease. J Neural Transm 111:69–89.
Panza F, D’Introno A, et al. (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51:275–292.
Pasquier F, Boulogne A, (2006) Diabetes mellitus and dementia. Diabetes Metab 32:403–414.
Perren F, Clarke S, et al. (2005) The syndrome of combined polar and paramedian thalamic infarction. Arch Neurol 62:1212–1216.
Pfrieger FW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 60:1158–1171.
Pohjasvaara T, Erkinjuntti T, et al. (1998) Clinical determinants of poststroke dementia. Stroke 29:75–81.
Pohjasvaara T, Mantyla R, et al. (2000) Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia: National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l’Enseignement en Neurosciences. Stroke 31:2952–2957.
Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme an amyloid beta peptide in Alzheimer’s disease: Review and hypothesis. Neurobiol Aging 27:190–198.
Reitz C, Tang MX, et al. (2004) Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61:705–714.
Ringelstein EB, Nabavi DG (2005) Cerebral small vessel diseases: cerebral microangiopathies. Curr Opin Neurol 18:179–188.
Rockwood K, Bowler J, (1999) Subtypes of vascular dementia. Alzheimer Dis Assoc 13 (suppl 3):59–65.
Rockwood K, Wentzel C, et al. (2000) Prevalence and outcomes of vascular cognitive impairment. Neurology 54:447–451.
Rodriguez G, Vitali P, et al. (2000) Hippocampal perfusion in mild cognitive impairment. Psychiatry Res 100:65–74.
Roman GC (2004) Facts, myths, and controversies in vascular dementia. J Neurol Sci 226:49–52.
Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1:426–436.
Roth A, Gill R, et al. (2003) Temporal and spatial gene expression patterns after experimental stroke in a rat model and characterization of pc4, a potential regulator of transcription. Mol Cell Neurosci 22:353–364.
Ruchoux MM, Brulin P, et al. (2000) Skin biopsy value and leukoaraiosis. Ann NY Acad Sci 903:285–292.
Sabatini T, Frisoni GB, et al. (2000) Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc 48:387–390.
Schaller B, Graf R (2004) Cerebral ischemia and reperfusion: The pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 24:351–371.
Schmidt-Kastner R, Zhang B, et al. (2002) DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain Res 108:81–93.
Schneider A, Gutbrod K, et al. (1996) Memory without context: Amnesia with confabulations after infarction of the right capsular genu. J Neurol Neurosurg Psychiatry 61:186–193.
Schramm M, Falkai P, et al. (1999) Stability of rna transcripts in post-mortem psychiatric brains. J Neural Transm 106:329–335.
Shin HK, Dunn AK, et al. (2006) Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 26:1018–1030.
Simons M, Keller P, et al. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Nat Acad Sci USA 95:6460–6464.
Sjöbeck M, Englund E (2003) Glial levels determine severity of white matter disease in Alzheimer’s disease-A neuropathological study of glial changes. Neuropathol Appl Neurobiol 29:159–169.
Skoog I,Gustafson D (2006) Update on hypertension and Alzheimer’s disease. Neurol Res 28:605–611.
Slevin M, Krupinski J, et al. (2005) Gene activation and protein expression following ischaemic stroke: Strategies towards neuroprotection. J Cell Mol Med 9:85–102.
Slevin M, Kumar P, et al. (2006) Can angiogenesis be exploited to improve stroke outcome?. Mechanisms and therapeutic potential. Clin Science 111:171–183.
Snowdon DA, Greiner L, et al. (1997) Brain infarction and the clinical expresion of Alzheimer’s disease. The Nun Study. JAMA 227:813–817.
Solé-Padullés C, Bartrés-Faz D, et al. (2004) Poorer cognitive performance in humans with mild cognitive impairment carrying the T variant of the Glu/Asp NOS3 polymorphism. Neurosci Lett 358:5–8.
Soriano MA, Tessier M, et al. (2000) Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J Cereb Blood Flow Metab 20:1045–1055.
Stenson PD, Ball EV, et al. (2003) Human gene mutation database (HGMD): 2003 update. Hum Mutat 21:577–581.
Stephens S, Kenny RA, et al. (2004) Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int J Geriatr Psychiatry 19:1053–1057.
Szatmari S, Fekete I, et al. (1999) Screening of vascular cognitive impairment on an Hungarian cohort. Psychiatry Clin Neurosci 53:39–43.
Taguchi A, Soma T, et al. (2004) Administration of cd34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330–338.
Tang Y, Lu A, et al. (2002) Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15:1937–1952.
Tatemichi TK, Desmond DW, et al. (1992) Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 42:1966–1979.
Thomas T, Thomas G, et al. (1996) Beta-amyloid mediated vasoactivity and vascular endothelial damage. Nature 380:168–171.
Tsai PT, Ohab JJ, et al. (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26:1269–1274.
Turu MM, Slevin M, et al. (2008) C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling patways and gene expression. BMC Cell Biol 9:4.
Tzourio C (2007) Hypertension, cognitive decline, and dementia: An epidemiological perspective. Dialogues Clin Neurosci 9:61–70.
Utter S, Tamboli IY, et al. (2008) Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J Neuropathol Exp Neurol 67:842–856.
Vagnucci AH, Jr., Li WW (2003) Alzheimer’s disease and angiogenesis. Lancet 361:605–608.
Van Oijen M, de Jong FJ, et al. (2007) Atherosclerosis and risk for dementia. Ann Neurol 61:403–410.
Van Zandvoort MJ, De Haan EH, et al. (2001) Chronic cognitive disturbances after a single supratentorial lacunar infarct. Neuropsychiatry Neuropsychol Behav Neurol 14:98–102.
Vermeer SE, Prins ND, et al. (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348:1215–1222.
Vikman P, Edvinsson L (2006) Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol 13:1324–1332.
Wald DS, Law M, et al. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202.
Waldstein SR, Rice SC, et al. (2008) Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 51:99–104.
Wallin A, Blennow K, et al. (1991) Subcortical symptoms predominate in vascular dementia. Int J Geriatr Psychiatry 6:137–146.
Wallin A, Edman A, et al. (1996) Stepwise comparative status analysis (STEP): A tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 9:185–199.
Wallin A, Sjögren M, et al. (2000) Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white matter changes in dementia. Eur Neurol 44:229–235.
White RP, Deane C, et al. (1998) Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperaemic response to hypercapnia. Stroke 29:467–472.
Wolfe N, Linn R, et al. (1990) Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 47:129–132.
Wolfe N, Babikian VL, et al. (1994) Are multiple cerebral infarcts synergistic? Arch Neurol 51:211–215.
Wu Z, et al. (2005) Role of the MEOX2 homebox gene in neurovascular dysfunction in Alzheimer’s disease. Nat Med 11:959–965.
Yaffe K, Kanaya A, et al. (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237–2242.
Yamamoto H, Nagata I, et al. (2003) Evaluation of mcao stroke models in normotensive rats: Standardized neocortical infarction by the 3vo technique. Exp Neurol 182:261–274.
Young SE, Mainous AG, et al. (2006) Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 29:2688–2693.
Yu SW, Friedman B, et al. (2007) Stroke-evoked angiogenesis results in a transient population of microvessels. J Cereb Blood Flow Metab 27:755–763.
Zacchigna S, Lambrechts D, et al. (2008) Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 9:169–181.
Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491–500.
Zhao BQ, Wang S, et al. (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441–445.
Zekry D, Duyckaerts C, et al. (2002) Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol 103:481–487.
Zekry D (2009) Is it possible to treat vascular dementia? Front Neurol Neurosci 24:95–106.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Arboix, A., Grau-Olivares, M., Krupinski, J. (2010). Vascular Development, Stroke and Neurodegenerative Disease: A Place for Novel Clinical Interventions?. In: Slevin, M. (eds) Therapeutic Angiogenesis for Vascular Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9495-7_14
Download citation
DOI: https://doi.org/10.1007/978-90-481-9495-7_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9494-0
Online ISBN: 978-90-481-9495-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)